arrow
S

Sophie Paczesny

Medical University of South Carolina
H指数:51
被引数:9,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells

专家小组评审及工程化免疫效应细胞生物标志物检测的实用指南

2026-05-160
OAAI
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia

DLK1是GATA1s驱动的依赖性和唐氏综合征相关髓系白血病的治疗靶点

2026-04-090
OAAI
Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation
2025-12-130
PRE
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation

移植后环磷酰胺可改善HLA-DPB1错配的无关供者异基因移植的生存率

2025-10-010
PRE
Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years

慢性移植物抗宿主病在10岁及以下儿童和10岁以上儿童/成人中的风险生物标志物

2025-09-200
OAAI
ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche

ST2/IL-33轴阻断抑制白血病微环境中调节性T细胞对CD8 T细胞的细胞毒性

2025-07-210
OAAI
Inflammatory markers and microbiome dysbiosis in hematopoietic cell transplant recipients with lung graft-versus-host disease

炎症标志物和微生物组失调在发生肺部移植物抗宿主病的造血细胞移植受者中的研究

2025-06-010
PRE
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation

儿科移植与细胞治疗联盟RESILIENT会议:造血细胞移植后儿科慢性移植物抗宿主病生存状况——第二部分。造血细胞移植后儿童慢性移植物抗宿主病的器官功能障碍与免疫重建考量。

2025-01-010
PRE
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
2024-04-027
OAAI